Palantir Faces a Pivotal Earnings Reckoning as Sector Jitters and Sky-High Valuations Collide

The selloff that swept through enterprise software this week has added a fresh layer of pressure to Palantir’s already fraught earnings narrative. The data analytics specialist saw its shares tumble 7.2% on Thursday, caught in a downdraft triggered by disappointing results from IBM and a brutal 18% plunge in ServiceNow. The cloud-software company pointed to delayed contract signings in the Middle East linked to stalled US-Iran negotiations and warned that near-term AI investments were squeezing margins. Salesforce, Oracle, and Intuit all suffered losses of between 3% and 4.5% as the selling spread. For Palantir, the damage was purely thematic rather than fundamental—but it underscores how little patience the market has for any whiff of trouble in the sector.

The stock now trades at around €124.28, roughly 13% below where it started the year and nearly 31% off its 52-week high set last November. That drawdown has done little to dent the valuation: even after the recent retreat, Palantir commands a market capitalization of roughly $338 billion, with a price-to-earnings ratio exceeding 200 times trailing earnings and a forward P/E of 118. The price-to-sales multiple stands at 87 times. Those are numbers that leave virtually no margin for error—a reality that will come into sharp focus when the company reports first-quarter results after the US market close on May 4.

The Commercial Engine Must Keep Humming

Analysts are looking for quarterly revenue of $1.54 billion, which would represent a blistering 74% increase from the same period last year. Management’s own guidance, issued in February, pointed to a range of $1.532 billion to $1.536 billion, with earnings per share expected at $0.28, more than double the $0.13 reported a year earlier. Morgan Stanley sees potential for a slight acceleration and a possible upward revision to full-year targets, but the investment bank also warns of the enormous downside risk. At a P/E above 220, record quarters are already priced in; any stumble, no matter how small, could trigger a sharp valuation reset.

The critical swing factor lies in the US commercial business. In the fourth quarter of 2025, that segment posted an extraordinary 137% revenue surge, helping drive overall sales growth of 70% to $1.41 billion for the period. For the full year 2025, total revenue climbed 56% to $4.48 billion, with the company holding $7.2 billion in net liquidity and carrying no debt. The challenge now is sustaining that commercial momentum, particularly as the government side of the business is expected to cool. Analysts project that growth in the government segment will slow from recent elevated rates to 42% in 2026 and 31% in 2027.

Should investors sell immediately? Or is it worth buying Palantir?

A Strategic Win That May Take Time to Pay Off

There is a bright spot on the government front that could eventually provide a more predictable revenue stream. Palantir’s Maven Smart System has been formally designated as a standard program by the Pentagon, a status that converts irregular software budgets into recurring, long-term funding. That structural shift should help stabilize what has historically been a lumpy government revenue line, but it may take several quarters to show up meaningfully in the numbers.

The broader market debate swirling around Palantir extends beyond its own results. Investors are increasingly questioning whether generative AI tools are cannibalizing demand for traditional enterprise software altogether. That existential concern, combined with the company’s extreme valuation and a prominent short position taken by Michael Burry, has kept the stock under persistent pressure.

The Earnings Verdict

When Palantir steps into the earnings spotlight on May 4, the market will be looking for more than just strong growth. It will be looking for evidence that the growth is fast enough—and sustainable enough—to justify a valuation that punishes even the smallest misstep. A clean beat on the commercial side could help quiet the valuation critics, but any disappointment, especially in the US business, risks sending the stock sharply lower in an already jittery market.